Jenusaitis Matthew has filed 4 insider transactions across 1 company since December 2023.
Most recent transaction: a grant/award of 135883 shares of enVVeno Medical Corp ($NVNO) on December 11, 2025.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 11, 2025 | enVVeno Medical Corp | $NVNO | Jenusaitis Matthew | Director | A | Stock Options | 135883 | $0.00 | 135,883.0000 | 20,286,000 | 9999.99% | 0.67% |
| Dec. 19, 2024 | enVVeno Medical Corp | $NVNO | Jenusaitis Matthew | Director | P | Common Stock | 9620 | $2.53 | 16,545.0000 | 16,067,000 | 138.92% | 0.06% |
| Dec. 18, 2024 | enVVeno Medical Corp | $NVNO | Jenusaitis Matthew | Director | A | Stock Options | 19752 | $0.00 | 19,752.0000 | 16,067,000 | 9999.99% | 0.12% |
| Dec. 5, 2023 | enVVeno Medical Corp | $NVNO | Jenusaitis Matthew | Director | A | Stock Options | 13856 | $0.00 | 13,856.0000 | 0 | 9999.99% | 0.00% |